-
EP3866808
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3866808
| EP3866808 - NOVEL USES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 27.09.2024 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 23.07.2021 | ||
| Former | The international publication has been made Status updated on 02.05.2020 | Most recent event Tooltip | 01.10.2024 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Intra-Cellular Therapies, Inc. 430 East 29th Street, Suite 900 New York, NY 10016 / US | [2021/34] | Inventor(s) | 01 /
DAVIS, Robert E. c/o Intra-Cellular Therapies, Inc. 430 East 29th Street Suite 900 New York, New York 10016 / US | 02 /
VANOVER, Kimberly E. c/o Intra-Cellular Therapies, Inc. 430 East 29th Street Suite 900 New York, New York 10016 / US | [2021/34] | Representative(s) | Synergy IP Group AG Leonhardsgraben 52 Postfach 4001 Basel / CH | [N/P] |
| Former [2021/34] | Pharma Patents International AG Leonhardsgraben 52 4051 Basel / CH | Application number, filing date | 19877180.0 | 21.10.2019 | [2021/34] | WO2019US57260 | Priority number, date | US201862748517P | 21.10.2018 Original published format: US 201862748517 P | [2021/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020086481 | Date: | 30.04.2020 | Language: | EN | [2020/18] | Type: | A1 Application with search report | No.: | EP3866808 | Date: | 25.08.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.04.2020 takes the place of the publication of the European patent application. | [2021/34] | Search report(s) | International search report - published on: | US | 30.04.2020 | (Supplementary) European search report - dispatched on: | EP | 15.03.2023 | Classification | IPC: | A61K31/519, A61P25/16, C07D487/12, C07D487/14 | [2022/46] | CPC: |
A61P25/16 (EP,IL,KR,US);
A61K31/519 (EP,KR,US);
C07D487/14 (EP,IL,KR)
|
| Former IPC [2021/34] | A61K31/519, C07D487/12, C07D487/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/34] | Title | German: | NEUARTIGE VERWENDUNGEN | [2021/34] | English: | NOVEL USES | [2021/34] | French: | NOUVELLES UTILISATIONS | [2021/34] | Entry into regional phase | 07.05.2021 | National basic fee paid | 07.05.2021 | Search fee paid | 07.05.2021 | Designation fee(s) paid | 07.05.2021 | Examination fee paid | Examination procedure | 07.05.2021 | Examination requested [2021/34] | 02.10.2023 | Amendment by applicant (claims and/or description) | 30.09.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 21.10.2021 | Renewal fee patent year 03 | 26.10.2022 | Renewal fee patent year 04 | 11.10.2023 | Renewal fee patent year 05 | 26.09.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2009075784 (INTRA CELLULAR THERAPIES INC [US], et al); | [I]WO2018069312 (DEUTSCHES ZENTRUM FUER NEURODEGENERATIVE ERKRANKUNGEN E V DZNE [DE], et al); | International search | [A]US6943171 (ASBEROM THEODROS [US], et al); | [A]US7964607 (VERHOEST PATRICK ROBERT [US], et al); | [A]US2013085123 (LI PENG [US], et al); | [A]US2017291904 (LI PENG [US], et al) |